Optimind Pharma (XCNQ:OMND) EBIT per Share : C$-0.03 (TTM As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma EBIT per Share?

Optimind Pharma's EBIT per Share for the three months ended in Nov. 2023 was C$-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2023 was C$-0.03.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Optimind Pharma's EBIT per Share or its related term are showing as below:

XCNQ:OMND's 3-Year EBIT Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 7.3
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Optimind Pharma's EBIT for the three months ended in Nov. 2023 was C$-0.08 Mil.

Optimind Pharma EBIT per Share Historical Data

The historical data trend for Optimind Pharma's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma EBIT per Share Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

EBIT per Share

-0.04

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
EBIT per Share	Get a 7-Day Free Trial			-	-0.02	-	-	-

Optimind Pharma EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Optimind Pharma's EBIT per Share for the fiscal year that ended in Feb. 2023 is calculated as

	EBIT per Share		(A: Feb. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.013	/	81.991
=	-0.04

Optimind Pharma's EBIT per Share for the quarter that ended in Nov. 2023 is calculated as

	EBIT per Share		(Q: Nov. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.079	/	98.092
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.03

Optimind Pharma (XCNQ:OMND) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Optimind Pharma EBIT per Share Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines